Brain rehabilitation app maker Constant Therapy, Inc. has raised $2 million Series A in a round led by Golden Seeds that included Kapor Capital, Launchpad Venture Group, Pond Capital and Community Health Network of Connecticut.

Founded in 2013, Constant Therapy provides iPad tools for continuous and personalized therapy to people with cognitive, language, communication and learning disorders.

The idea for the company came out of research at Boston University and in pilots with prominent and nationally recognized rehabilitation institutions, with the tools claimed to be revolutionizing the treatment of speech, language, and cognitive disorders by using science-based digital brain therapy delivered on mobile devices.

Constant Therapy provides a comprehensive set of tools for care to people who have suffered a traumatic brain injury (TBI), stroke or dementia, or children who need special education and care due to learning disabilities or other disorders.

Therapy tasks are said to be based on ongoing research and are easy to use, and include 50 categories of tasks and over 12,000 items allowing patients to continue to improve their well being at home even after traditional care ends in the clinic.

The company and its app have already earned widespread praise from national organizations including the American Heart Association People’s Choice Award for Best Health Technology, AARP 2015 Consumer Choice Award for Health Innovation and Village Capital and Global Health & Social Innovation Capital Partners Award.

“Constant Therapy quite literally puts speech, language, and cognitive therapy in your pocket,” Constant Therapy Chief Executive Officer Keith Cooper said in a statement sent to SiliconANGLE. “Developed by some of the world’s foremost experts in brain rehabilitation, it allows us to harness both data and science to optimize the effectiveness of treatment, customize it for each patient and then deliver it for individual use, or as an integral part of clinician-led therapy.”

Big market

According to the company, there is currently a $10 billion market for brain rehabilitation services, and it’s a market ripe for disruption given today it primarily run using traditional paper-based therapies that rely on static and manually delivered exercises.

It sounds great on paper and is already being used by brain rehabilitation service providers, including the Spaulding Rehabilitation Network, the Stroke Comeback Center and The MossRehab Aphasia Center.

Including the new round Constant Therapy has raised $2.74 million to date; previous investors include Andy Palmer and Boston University.

The company said it would use the new funds to enable them to expand the scientific research, data, marketing and development behind its product.

If you are a patient or know someone who might be interested in the product, the program can be accessed by purchasing a subscription to Constant Therapy for $19.99 per month, $199.99 per year or $299.99 for three years, and is available from Google Play, the Apple App Store, and Amazon’s Kindle App Store.

Image credit: Constant Therapy/ screenshot.